Sienna Biopharmaceuticals, Inc.
SNNAQ
$0.00
$0.000.00%
OTC PK
| 09/30/2019 | 06/30/2019 | 03/31/2019 | 12/31/2018 | 09/30/2018 | |
|---|---|---|---|---|---|
| Net Income | 76.36% | 59.17% | 4.22% | -72.80% | -2.46% |
| Total Depreciation and Amortization | -7.69% | -5.13% | 0.00% | 0.00% | 44.44% |
| Total Amortization of Deferred Charges | 304.62% | -- | -- | -- | -- |
| Total Other Non-Cash Items | -758.50% | 41.11% | 415.06% | 430.91% | -78.26% |
| Change in Net Operating Assets | -4,060.30% | -131.16% | -319.80% | -48.79% | -107.48% |
| Cash from Operations | -12.30% | 46.56% | 11.66% | -10.78% | -69.03% |
| Capital Expenditure | 100.00% | 100.00% | 0.00% | 94.23% | 83.33% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.00% | 100.00% | 0.00% | 94.23% | 83.33% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -43.14% | -- | -- | -92.41% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -500.56% | -98.53% | 119,133.33% | -- | -92.48% |
| Foreign Exchange rate Adjustments | -- | 105.45% | -143.48% | -368.63% | -100.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -246.80% | -153.53% | 159.80% | -9.30% | -119.18% |